Results 71 to 80 of about 6,343 (174)

Simple one-pot green method for large-scale production of mesalamine, an anti-inflammatory agent

Green Processing and Synthesis, 2019
We report a rapid and efficient synthesis protocol for mesalamine via a green approach with 2-chloro-5-nitrobenzoic acid as the starting material, for its large-scale production.
Vijaya Lakshmi C., Katari Naresh Kumar, Jonnalagadda Sreekantha B.   +2 more
doaj   +1 more source

Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease

JGH Open, 2019
Background and Aim The literature on medication adherence in patients with inflammatory bowel disease (IBD) is heterogeneous. The present study aimed to identify the rates and predictors of nonadherence to medications in IBD. Methods This cross‐sectional
Sanjeevani K Tomar, Saurabh Kedia, Namrata Singh, Ashish D Upadhyay, Nagesh Kamat, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Saransh Jain, Govind Makharia, Vineet Ahuja   +10 more
doaj   +1 more source

Endoscopic and clinicopathological features of segmental colitis associated with diverticulosis

DEN Open
Objectives Segmental colitis associated with diverticulosis (SCAD) has close endoscopic and pathological similarities to ulcerative colitis (UC) and Crohn's disease. Clinical data on SCAD are limited in Japan.
Kazuhiko Obata, Kan Uchiyama, Ryuzo Murai   +2 more
doaj   +1 more source

Mesalamine: Safe at first look [PDF]

Inflammatory Bowel Diseases, 1999
L J, Saubermann, J L, Wolf
openaire   +2 more sources

Development and validation of an in vitro permeation test method for rectal mesalamine suppositories. [PDF]

Int J Pharm
Xie L, Kelchen M, Ghosh P, Niu M, Raney SG, Shen J.   +5 more
europepmc   +1 more source

Associations Between Depression and Gastrointestinal Disorders in a Large Real-World Cohort. [PDF]

Cureus
Gong TM, Li Z, Mula M, Espiridion E.
europepmc   +1 more source

Balancing Act: Lessons From Comanaging Patients With Inflammatory Bowel Disease and HIV/AIDS. [PDF]

ACG Case Rep J
Cruz Grave E, Paik P, Kim J, Odufalu FD.
europepmc   +1 more source

Semaglutide-Induced Symptomatic Remission in Ulcerative Colitis. [PDF]

ACG Case Rep J
Alqinai B, Adeniran O, Adekolu A, Gayam S.   +3 more
europepmc   +1 more source

Design and biological evaluation of mesalamine-NSAID hybrids targeting the NLRP3 inflammasome: a multi-target strategy for ulcerative colitis therapy. [PDF]

Sci Rep
Yahya M, Safaei-Ghomi J, Haghir-Ebrahimabadi A, Jalali H, Mojtabazadeh H.   +4 more
europepmc   +1 more source

pH-responsive hyaluronic acid-co-poly(acrylic acid) hydrogel scaffolds for modified release of mesalamine; characterization and biosafety evaluation. [PDF]

RSC Adv
Liaqat H, Minhas MU, Badshah SF, Barkat K, Khan S, Chopra S, Chopra H, Alyami EM, Metouekel A, Asrat Mengistie A, Elossaily GM, Shahid M.   +11 more
europepmc   +1 more source